{"sections":{"main":{"type":"main-page","disabled":true,"settings":{"padding_top":28,"padding_bottom":28,"alignment_title":"left"}},"e2b7edc1-d652-4618-b007-0003c3d77ed7":{"type":"hero-section-3","blocks":{"template--15291250016349__e2b7edc1-d652-4618-b007-0003c3d77ed7-16651460428fa33091-0":{"type":"heading","settings":{"heading":"Suprax","heading_size":"medium","show_line":false}},"template--15291250016349__e2b7edc1-d652-4618-b007-0003c3d77ed7-16651460428fa33091-1":{"type":"text","settings":{"text":"Cefixime, found in Suprax, is a type of antibiotic. By combating bacteria in your body, it works. Suprax is prescribed to treat a wide range of bacterial infections. For viral infections (such as the common cold or flu), this medication is ineffective. This article serves as information for Welzo users to better understand 5-HTP."}},"3697b572-00b3-4873-aadb-01e85df03254":{"type":"button","settings":{"button_label":"Overview","button_link":""}},"c39256d7-f8c0-462f-9109-cc5c53138458":{"type":"button","settings":{"button_label":"Uses","button_link":""}},"e1738aef-38ac-4846-bb48-4dbbbbed5d87":{"type":"button","settings":{"button_label":"Side Effects","button_link":""}},"02803003-6821-40cf-95ac-12d635aeedde":{"type":"button","settings":{"button_label":"Medication","button_link":""}},"6dd2932b-340e-4452-9c4a-96e1a9b89318":{"type":"button","settings":{"button_label":"Ingredients","button_link":""}},"7cfda700-4c13-4a17-9f5a-f70032e2217f":{"type":"button","settings":{"button_label":"Supplements","button_link":""}},"9507a9fe-9b42-4083-bc48-a0a94b4ace7a":{"type":"button","settings":{"button_label":"Pharmacokinetics","button_link":""}},"template--15291250016349__e2b7edc1-d652-4618-b007-0003c3d77ed7-16651460428fa33091-3":{"type":"image","settings":{"image":"shopify:\/\/shop_images\/image-6_b7f6fcb4-8845-4717-b965-163be88cd4b7.png"}}},"block_order":["template--15291250016349__e2b7edc1-d652-4618-b007-0003c3d77ed7-16651460428fa33091-0","template--15291250016349__e2b7edc1-d652-4618-b007-0003c3d77ed7-16651460428fa33091-1","3697b572-00b3-4873-aadb-01e85df03254","c39256d7-f8c0-462f-9109-cc5c53138458","e1738aef-38ac-4846-bb48-4dbbbbed5d87","02803003-6821-40cf-95ac-12d635aeedde","6dd2932b-340e-4452-9c4a-96e1a9b89318","7cfda700-4c13-4a17-9f5a-f70032e2217f","9507a9fe-9b42-4083-bc48-a0a94b4ace7a","template--15291250016349__e2b7edc1-d652-4618-b007-0003c3d77ed7-16651460428fa33091-3"],"settings":{"body_text":"#12022f","padding_top":36,"padding_bottom":150}},"5cbe206a-8974-430b-ab53-0d3a9890d088":{"type":"simple_text","blocks":{"template--15389620011101__5cbe206a-8974-430b-ab53-0d3a9890d088-1673004137a8fb07c4-0":{"type":"heading","settings":{"heading":"Side Effects"}},"template--15389620011101__5cbe206a-8974-430b-ab53-0d3a9890d088-1673004137a8fb07c4-1":{"type":"text","settings":{"text":"<p>Suprax side effects could be unnecessary or unwanted. These consist of:<br\/><br\/>mild abdominal pain and diarrhea;<br\/><br\/>headache and fatigue<br\/><br\/>or vaginal discharge or itching<br\/><br\/>rash.<br\/><br\/>Inform your doctor or pharmacist as soon as possible if any of these side effects persist or get worse.<br\/><br\/>Suprax should only be used to treat or prevent infections that are known to be caused by bacteria, or for which there is a high probability, in order to prevent the emergence of drug-resistant bacteria and preserve the efficacy of Suprax and other antibacterial medications.<br\/><br\/><br\/><\/p>"}}},"block_order":["template--15389620011101__5cbe206a-8974-430b-ab53-0d3a9890d088-1673004137a8fb07c4-0","template--15389620011101__5cbe206a-8974-430b-ab53-0d3a9890d088-1673004137a8fb07c4-1"],"settings":{"padding_top":40,"padding_bottom":52}},"c23c9903-1d44-4abb-905d-51478af2e3ea":{"type":"simple_text","blocks":{"template--15389620011101__c23c9903-1d44-4abb-905d-51478af2e3ea-1673004153f6a3b721-0":{"type":"heading","settings":{"heading":"Pharmacokinetics"}},"template--15389620011101__c23c9903-1d44-4abb-905d-51478af2e3ea-1673004153f6a3b721-1":{"type":"text","settings":{"text":"<p>TABLE 1 Mean (%CV) Pharmacokinetic Parameters of Cefixime in Healthy Young Adultsa<\/p><p>The pharmacokinetic parameters of cefixime in healthy young adults are summarized in Table 1.<\/p><p>Parameter Subjects Dose (mg) 8400<\/p><p>N = 18 100 200 400<\/p><p>—————————————————————————————————————————————<\/p><p>Cmax (mcg\/mL) Males (n=8) 1.90 (16.6) 3.63 (20.1) 7.10 (23.0)<\/p><p>Females (n=10) 2.18 (21.9) 4.04 (17.3) 8.00 (22.0)<\/p><p>—————————————————————————————————————————————<\/p><p>Tmax (h) Males (n=8) 1.38 (0.58-3.00) 1.13 (0.50-2.00) 0.88 (0.25-2.00)<\/p><p>Females (n=10) 1.50 (0.42-4.25) 1.17 (0.50-1.75) 0.83 (0.33-2.00)<\/p><p>—————————————————————————————————————————————<\/p><p>AUC0–12(mcgh\/mL) Males (n=8) 9.55 (19.1) 18.75 (22.1) 35.18 (20.6)<\/p><p>Females (n=10) 10.63 (23.2) 20.00 (21.0) 37.33 (17.8)<\/p><p>—————————————————————————————————————————————<\/p><p>AUC0–∞(mcg•h\/mL) Males (n=8) 10.40 (19.7) 20.13 (24.4) 38.48 (20.9)<\/p><p>Females(n=10) 11.70 (25.5) 22.08 (23.3) 41 .50(18 .1 )<\/p><p>—————————————————————————————————————————————<\/p><p>aValues are mean (%CV).<\/p><p>Cmax: Maximum observed concentration<\/p><p>Tmax: Time of maximum observed concentration<\/p><p>AUC0–12: Area under the plasma concentration-time curve from time 0 to 12 hours post-dose<\/p><p>AUC0–∞: Area under the plasma concentration-time curve from time 0 to infinity<\/p><p>TABLE 2 Mean (%CV) Pharmacokinetic Parameters of Cefixime in Healthy Elderly Subjectsa (&gt; 65 Years Old)<\/p><p>Dose (mg) 8400<\/p><p>Parameter Subjects 100 200 400<\/p><p>—————————————————————————————————————————————<\/p><p>Cmax (mcg\/mL) Males (n=8) 1.90 (16.6) 3.63 (20.1) 7.10 (23.0)<\/p><p>Females (n=10) 2.18 (21.9) 4.04 (17.3) 8.00 (22.0)<\/p><p>—————————————————————————————————————————————<\/p><p>Tmax (h) Males (n=8) 1.38 (0.58-3.00) 1.13 (0.50-2.00) 0.88 (0.25-2 . 00 )<\/p><p>Females(n=10 ) 1 . 50(0 . 42 -4 . 25 ) 1 . 17(0 . 50 -1 . 75 ) 0 . 83 (0 . 33 -2 . 00 )<\/p><p>—————————————————————————————————————————————<\/p><p>AUC0 – 12(mcgh\/mL) Males (n=8) 9.55 (19.1) 18.75 (22.1) 35.18 (20.6)<\/p><p>Females(n=10 ) 10.63 (23.2) 20.00 (21.0) 37 .33(17 . 8 )<\/p><p>—————————————————————————————————————————————<\/p><p>AUC0 –∞(mcg•h\/mL)(b) Males(n=8 ) 10 . 40(19 . 7 ) 20 . 13(24 . 4 ) 38 . 48 (20 . 9 )<\/p><p>Females(n=10) 11.70 (25.5) 22.08 (23.3) 41 .50(18 . 1 )<\/p><p>—————————————————————————————————————————————<\/p><p>aValues are mean (%CV).<\/p><p>bAUC0- ∞: Area under the plasma concentration – time curve from time 0 extrapolated to infinity<\/p><p>TABLE 3 Mean (%CV) Pharmacokinetic Parameters of Cefixime in Healthy Elderly Males (&gt; 65 Years Old) and Females (&gt; 65 Years Old)(a,b)<\/p><p>Dose (mg)(c) 8400<\/p><p>Parameter Subjects 100 200 400 800<\/p><p>—————————————————————————————————————————————<\/p><p>Cmax(mcg\/mL) Males (n=8) 1.90 (16.6) 3.63 (20.1) 7.10 (23.0) 10.13 (25.7)<\/p><p>Females(n=8 ) 2 . 18(21 . 9 ) 4 . 04(17 . 3 ) 8.00 (22.0) 11 .67(21 . 5 )<\/p><p>—————————————————————————————————————————————<\/p><p>Tmax h) Males (n=8) 1.38 (0.58-3.00) 1.13 (0,50-2,00) 0,88 (0 , 25 -2 , 00) 0.67 (0.08-1 . 00)<\/p><p>Females(n=8 ) 1 . 50(0 . 42 -4 . 25 ) 1 . 17(0 . 50 -1 . 75 ) 0.83 (0,33-2,00) 0.58 (0.08-1.17)<\/p><p>—————————————————————————————————————————————<\/p><p>AUC0 –12 (mcg•h\/mL)(d) Males (n=8) 9 , 55(19 , 1 ) 18 , 75(22 , 1 ) 35,18 (20,6) 51 , 20(21 , 3 )<\/p><p>Females (n=8) 10.63 (23.2) 20.00 (21.0) 37,33 (17 , 8 ) 55 .83(19 . 4 )<\/p><p>—————————————————————————————————————————————<\/p><p>AUC0 –∞ (mcg•h\/mL)(e) Males(n=8 ) 10 , 40(19 , 7 ) 20 , 13(24 , 4 ) 38,48 (20,9) 54 , 88(22 , 2 )<\/p><p>Females(n=8 ) 11.70 (25.5) 22.08 (23.3) 41,50 (18 . 1 ) 58 , 58(20 . 5 )<\/p><p>aValues are mean (%CV).<\/p><p>bAUC0- ∞: Area under the plasma concentration – time curve from time 0 extrapolated to infinity<\/p><p>cThe 8400 mg dose was administered as four 2200-mg doses given as 600 mg every 4 hours for 12 hours.<\/p><p>dAUC0 –12 (mcg•h\/mL): Area under the plasma concentration – time curve from time 0 to 12 hours.<\/p><p>eAUC0 –∞ (mcg•h\/mL): Area under the plasma concentration – time curve from time 0 extrapolated to infinity.<\/p><p>TABLE 4 Mean (%CV) Pharmacokinetic Parameters of Cefixime in Healthy Elderly Males (&gt; 65 Years Old) and Females (&gt; 65 Years Old)(a,b)<\/p><p>Dose (mg)(c) 8400<\/p><p>Parameter Subjects 100 200 400 800<\/p><p>—————————————————————————————————————————————<\/p><p>Cmax(mcg\/mL) Males (n=8) 1.90 (16.6) 3.63 (20.1) 7.10 (23.0) 10.13 (25.7)<\/p><p>Females(n=8 ) 2 . 18(21 . 9 ) 4 . 04(17 . 3 ) 8.00 (22.0) 11 .67(21 . 5 )<\/p><p>—————————————————————————————————————————————<\/p><p>Tmax h) Males (n=8) 1.38 (0.58-3.00) 1.13 (0,50-2,00) 0,88 (0 , 25 -2 , 00) 0.67 (0.08-1 . 00)<\/p><p>Females(n=8 ) 1 . 50(0 . 42 -4 . 25 ) 1 . 17(0 . 50 -1 . 75 ) 0.83 (0,33-2,00) 0.58 (0.08-1.17)<\/p><p>—————————————————————————————————————————————<\/p><p>AUC0 –12 (mcg•h\/mL)(d) Males (n=8) 9 , 55(19 , 1 ) 18 , 75(22 , 1 ) 35,18 (20,6) 51 , 20(21 , 3 )<\/p><p>Females (n=8) 10.63 (23.2) 20.00 (21.0) 37,33 (17 , 8 ) 55 .83(19 . 4 )<\/p><p>—————————————————————————————————————————————<\/p><p>AUC0 –∞ (mcg•h\/mL)(e) Males(n=8 ) 10 , 40(19 , 7 ) 20 , 13(24 , 4 ) 38,48 (20,9) 54 , 88(22 , 2 )<\/p><p>Females(n=8 ) 11.70 (25.5) 22.08 (23.3) 41,50 (18 . 1 ) 58 , 58(20 . 5 )<\/p><p>aValues are mean (%CV).<\/p><p>bAUC0- ∞: Area under the plasma concentration – time curve from time 0 extrapolated to infinity<\/p><p>cThe 8400 mg dose was administered as four 2200-mg doses given as 600 mg every 4 hours for 12 hours.<\/p><p>dAUC0 –12 (mcg•h\/mL): Area under the plasma concentration – time curve from time 0 to 12 hours.<\/p><p>eAUC0 –∞ (mcg•h\/mL): Area under the plasma concentration – time curve from time 0 extrapolated to infinity.<\/p>"}}},"block_order":["template--15389620011101__c23c9903-1d44-4abb-905d-51478af2e3ea-1673004153f6a3b721-0","template--15389620011101__c23c9903-1d44-4abb-905d-51478af2e3ea-1673004153f6a3b721-1"],"settings":{"padding_top":40,"padding_bottom":52}},"72bfe1fd-a8af-4b9c-87e0-49c91e03bfdc":{"type":"simple_text","blocks":{"template--15389620011101__72bfe1fd-a8af-4b9c-87e0-49c91e03bfdc-1673004153f6a3b721-0":{"type":"heading","settings":{"heading":"Dosage and administration"}},"template--15389620011101__72bfe1fd-a8af-4b9c-87e0-49c91e03bfdc-1673004153f6a3b721-1":{"type":"text","settings":{"text":"<p>Cefixime is typically taken 400 mg once daily. 800 mg may be required as a higher dose for some infections. The 400-mg tablet should be swallowed whole with a glass of water rather than being chewed or crushed.<br\/><br\/>You can take cefixime with or without food. Your body will absorb less of the medication if you take it with food. Cefixime must be taken on a regular basis to be most effective. Antacids shouldn't be consumed two hours before or after taking cefixime.<br\/><br\/>Your doctor may perform a test on you if you are taking cefixime to prevent gonorrhea to make sure you do not also have syphilis, another sexually transmitted disease.<br\/><\/p>"}}},"block_order":["template--15389620011101__72bfe1fd-a8af-4b9c-87e0-49c91e03bfdc-1673004153f6a3b721-0","template--15389620011101__72bfe1fd-a8af-4b9c-87e0-49c91e03bfdc-1673004153f6a3b721-1"],"settings":{"padding_top":40,"padding_bottom":52}},"6f8de598-5300-44af-a06b-04ebf8522782":{"type":"simple_text","blocks":{"template--15389620011101__6f8de598-5300-44af-a06b-04ebf8522782-1673004153f6a3b721-0":{"type":"heading","settings":{"heading":"To take cefixime suspension"}},"template--15389620011101__6f8de598-5300-44af-a06b-04ebf8522782-1673004153f6a3b721-1":{"type":"text","settings":{"text":"<p>Use the syringe or measuring spoon that came with the medicine. If you are unsure of how to measure your dose, ask your pharmacist for assistance.<br\/><br\/>Before each dose, give the bottle a good shake.<br\/><br\/>By turning the cap while applying pressure, you can open the bottle.<br\/><br\/>To take the medication orally, open the capsule and dispense the medication into 2.5 mL of water. Stir this concoction and consume it all at once. Add a little more water to the same glass, give it a gentle swirl, and then immediately sip to ensure you've consumed the entire dose.<br\/><br\/>The 200 mg oral suspension capsule contains about 125 mg of cefixime as cefixime trihydrate. <br\/><\/p>"}}},"block_order":["template--15389620011101__6f8de598-5300-44af-a06b-04ebf8522782-1673004153f6a3b721-0","template--15389620011101__6f8de598-5300-44af-a06b-04ebf8522782-1673004153f6a3b721-1"],"settings":{"padding_top":40,"padding_bottom":52}}},"order":["main","e2b7edc1-d652-4618-b007-0003c3d77ed7","5cbe206a-8974-430b-ab53-0d3a9890d088","c23c9903-1d44-4abb-905d-51478af2e3ea","72bfe1fd-a8af-4b9c-87e0-49c91e03bfdc","6f8de598-5300-44af-a06b-04ebf8522782"]}